Category: Press Release - Page 18 - Psychedelic Alpha

Read more about the article atai Life Sciences Presents Pharmacodynamic Data on GRX-917 in a Late Breaking Poster Presentation at the 2023 SOBP Annual Meeting

atai Life Sciences Presents Pharmacodynamic Data on GRX-917 in a Late Breaking Poster Presentation at the 2023 SOBP Annual Meeting

Post published:April 28, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Forms a Data and Safety Monitoring Board to Oversee its First-in-Human Clinical Trial

Clearmind Medicine Forms a Data and Safety Monitoring Board to Oversee its First-in-Human Clinical Trial

Post published:April 27, 2023
Post category:Press Release

Read more about the article Reunion Neuroscience Announces Presentation at 2023 Bloom Burton & Co. Healthcare Investor Conference

Reunion Neuroscience Announces Presentation at 2023 Bloom Burton & Co. Healthcare Investor Conference

Post published:April 25, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES SPRING 2023 EVENT AND MEDIA APPEARANCES

FILAMENT HEALTH ANNOUNCES SPRING 2023 EVENT AND MEDIA APPEARANCES

Post published:April 25, 2023
Post category:Press Release

Read more about the article BetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, California

BetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, California

Post published:April 25, 2023
Post category:Press Release

Read more about the article Silo Pharma to Present at Psychedelic Drug Development Conference

Silo Pharma to Present at Psychedelic Drug Development Conference

Post published:April 24, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression

Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression

Post published:April 21, 2023
Post category:Press Release

Read more about the article MINDCURE Announces Financial Results for the Third Quarter of Fiscal 2023

MINDCURE Announces Financial Results for the Third Quarter of Fiscal 2023

Post published:April 21, 2023
Post category:Press Release

Read more about the article BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

Post published:April 20, 2023
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Reminds Shareholders of Previously Announced Rights Offering and Approaching Cut Off Date and Time

Algernon Pharmaceuticals Reminds Shareholders of Previously Announced Rights Offering and Approaching Cut Off Date and Time

Post published:April 20, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.